In focus

NI+ feature

‘Two sides of the same coin’: Industry and regulators signal a smarter, collaborative era for supplement oversight

27-May-2026 | Asia Sherman

At the first East Coast gathering of the SoCal Dietary Supplement Consortium, U.S. Food and Drug Administration officials and industry leaders framed supplement regulation around modernization, risk-based enforcement and practical collaboration.

News from NI+

Latest insights

After 12 years, Joint Juice litigation ends with $90M in settlements

09-Jun-2026 | Cassandra Stern

More than a decade after litigation began over joint health claims made by Joint Juice products, a California court on May 5 granted final approval to proposed settlements totaling approximately $90 million, bringing the multijurisdictional dispute to a close.

NASC pushes Animal Health Supplement Act to modernize oversight

08-Jun-2026 | Claudia Adrien

The National Animal Supplement Council (NASC) is advancing legislative efforts to move the companion animal supplement industry beyond a regulatory gray area.

Regulators clamp down on vitamin B6 as toxicity debate grows

08-Jun-2026 | Lauren Nicolle

Vitamin B6 is essential to human health, but excessive doses may cause serious side effects. As a growing number of countries tighten oversight of vitamin B6 supplements, debate is intensifying over whether the restrictions are proportionate to the risk.

FTC sues Amare over mental health supplement claims

04-Jun-2026 | Cassandra Stern

The U.S. Federal Trade Commission (FTC) has sued Amare Global Holdings Inc. (Amare) and three company executives, alleging the multilevel marketing company illegally marketed dietary supplements as treatments for depression, anxiety and ADHD in children and adults.

NARB decision tests limits of structure-function claims in NAD+ category

03-Jun-2026 | Cassandra Stern

A National Advertising Review Board (NARB) ruling affirming recommendations against claims made by Niagen Bioscences is raising broader questions about how supplement companies substantiate and market biomarker, cellular health and longevity-related benefits tied to NAD+ science.

Timeline: How a fermented food created a global drug regulation crisis

03-Jun-2026 | Olivia Haslam

Monacolin K from red yeast rice has exposed how a single naturally-occurring compound can blur the line between food, supplements and prescription drugs across global regulation.

France renews Garcinia cambogia ban, EU extends safety consultation

03-Jun-2026 | Nikki Hancocks

France has renewed the prohibition of food supplements containing Garcinia cambogia for an additional year as the European Council extends its consultation over the ingredient’s safety.

Taiwan planning new rules for Traditional Chinese Medicine products

03-Jun-2026 | Tingmin Koe

Taiwan’s Ministry of Health and Welfare is seeking comment on a new regulation that would clarify the distinction between “food” and “medicine” in Traditional Chinese Medicine (TCM) products while preserving the country’s long-standing food culture around herbal ingredients.

Is blood NAD+ a dead end in aging research?

02-Jun-2026 | Asia Sherman

An investigation into one of aging research’s most prominent molecules has reported that NAD+, a compound central to cellular metabolism, may not decline in human blood the way many in the aging and longevity community once thought.

intelligent Answers

Ask iA

Ask iA

Get clarity with intelligent Answers

Subscribers get unlimited use of iA for deep research of over 25 years of NutraIngredients reporting.

Ask a question.